Patents by Inventor Sam Khatami

Sam Khatami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Inhibiting or Reversing Tau Filament Fibrillization
    Publication number: 20090137643
    Abstract: Methods for inhibiting and/or reversing tau filament formation or fibrillization are provided. These methods can be used for treating certain neurological disorders in vivo by administering pharmaceutical compositions which inhibit and/or reverse tau filament formation or fibrillization. A preferred composition comprises 3-(2-hydroxyethyl )-2-[2-[[3-(2-hydroxyethyl )-5-methoxy-2-benzothiazolylidene]methyl]-1-butenyl]-5-methoxybenzothiazolium.
    Type: Application
    Filed: November 21, 2008
    Publication date: May 28, 2009
    Inventors: Jeff Kuret, Sam Khatami
  • Methods for inhibiting or reversing tau filament fibrillization
    Publication number: 20050032857
    Abstract: Methods for inhibiting and/or reversing tau filament formation or fibrillization are provided. These methods can be used for treating certain neurological disorders in vivo by administering pharmaceutical compositions which inhibit and/or reverse tau filament formation or fibrillization. A preferred composition comprises 3-(2-hydroxyethyl)-2-[2-[[3-(2-hydroxyethyl)-5-methoxy-2-benzothiazolylidene]methyl]-1-butenyl]-5-methoxybenzothiazolium.
    Type: Application
    Filed: June 21, 2004
    Publication date: February 10, 2005
    Inventors: Jeff Kuret, Sam Khatami
  • Methods for inhibiting or reversing tau filament formation polymerization
    Patent number: 6479528
    Abstract: Methods for inhibiting and/or reversing tau filament formation or polymerization are provided. These methods can be used for treating certain neurological disorders in vivo by administering pharmaceutical compositions which inhibit and/or reverse tau filament formation or polymerization. An especially preferred pharmaceutical composition contains an inhibitor of the general formula I wherein R1 is an aliphatic radical having one to six carbon atoms and wherein R2 and R3 independently are a second aliphatic radical having one to six carbon atoms, a hydroxyl-substituted aliphatic radical having one to six carbon atoms, or a pheny radical or a pharmaceutically acceptable salt of the inhibitor.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: November 12, 2002
    Assignee: Neuronautics, Inc.
    Inventors: Jeff Kuret, Sam Khatami